MultiCell Technologies, Inc. MCET

MCET Company Overview

MultiCell Technologies, Inc. (OTC: MCET) is a biotechnology company that historically focused on the development and commercialization of human liver cell technologies for pharmaceutical research, drug metabolism testing, toxicology screening, and bioartificial liver support applications. Public disclosures and historical company materials describe the company’s core scientific platform as involving immortalized human hepatocyte cell lines intended to replicate liver-specific metabolic functions for research and therapeutic use.

The company operated within the broader biotechnology and life sciences tools industries, serving pharmaceutical developers, academic researchers, and medical technology partners involved in liver disease research and drug safety evaluation. Historically, MCET positioned itself around proprietary hepatic cell technologies and collaborations related to extracorporeal liver-assist systems. Publicly available information indicates the company’s operational scale became limited over time, and recent independently verified disclosures regarding active commercial operations, revenue generation, or current product commercialization remain limited. Data inconclusive based on available public sources.